Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Capricor Therapeutics (CAPR) Receivables - Net (2023 - 2024)

Capricor Therapeutics (CAPR) has 3 years of Receivables - Net data on record, last reported at $10.0 million in Q4 2024.

  • For Q4 2024, Receivables - Net changed 0.0% year-over-year to $10.0 million; the TTM value through Dec 2024 reached $10.0 million, changed 0.0%, while the annual FY2024 figure was $10.0 million, 0.0% changed from the prior year.
  • Receivables - Net reached $10.0 million in Q4 2024 per CAPR's latest filing, roughly flat from $10.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $10.0 million in Q4 2023 and bottomed at $10.0 million in Q4 2023.